Evercore Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Sell
93,409
-8,311
-8% -$217K 0.03% 156
2026
Q1
$2.86M Sell
101,720
-5,317
-5% -$142K 0.04% 132
2025
Q4
$2.67M Buy
107,037
+4,338
+4% +$109K 0.04% 142
2025
Q3
$2.62M Sell
102,699
-16,403
-14% -$405K 0.04% 142
2025
Q2
$2.89M Sell
119,102
-14,901
-11% -$348K 0.04% 132
2025
Q1
$3.4M Sell
134,003
-9,733
-7% -$255K 0.05% 123
2024
Q4
$3.81M Sell
143,736
-29,647
-17% -$804K 0.06% 121
2024
Q3
$5.02M Sell
173,383
-23,655
-12% -$690K 0.08% 96
2024
Q2
$5.51M Sell
197,038
-9,852
-5% -$271K 0.09% 92
2024
Q1
$5.74M Sell
206,890
-10,464
-5% -$290K 0.09% 92
2023
Q4
$6.26M Sell
217,354
-17,615
-7% -$532K 0.1% 84
2023
Q3
$7.79M Sell
234,969
-12,988
-5% -$459K 0.15% 72
2023
Q2
$9.1M Sell
247,957
-3,898
-2% -$152K 0.17% 68
2023
Q1
$10.3M Sell
251,855
-6,662
-3% -$288K 0.2% 62
2022
Q4
$13.2M Sell
258,517
-6,902
-3% -$331K 0.28% 58
2022
Q3
$11.6M Sell
265,419
-3,200
-1% -$155K 0.26% 58
2022
Q2
$14.1M Sell
268,619
-2,178
-0.8% -$111K 0.3% 57
2022
Q1
$14M Buy
270,797
+71
+0% +$3.68K 0.25% 59
2021
Q4
$16M Sell
270,726
-5,825
-2% -$289K 0.26% 58
2021
Q3
$11.9M Sell
276,551
-10,281
-4% -$455K 0.22% 61
2021
Q2
$11.2M Sell
286,832
-12,975
-4% -$505K 0.21% 62
2021
Q1
$10.9M Sell
299,807
-40,870
-12% -$1.45M 0.22% 63
2020
Q4
$12.5M Buy
340,677
+378
+0.1% +$13.9K 0.27% 54
2020
Q3
$11.8M Buy
340,299
+1,084
+0.3% +$38K 0.29% 53
2020
Q2
$10.5M Sell
339,215
-15,940
-4% -$542K 0.28% 57
2020
Q1
$11M Sell
355,155
-3,430
-1% -$117K 0.36% 51
2019
Q4
$13.3M Sell
358,585
-16,468
-4% -$587K 0.36% 52
2019
Q3
$12.8M Sell
375,053
-8,482
-2% -$308K 0.38% 55
2019
Q2
$15.8M Buy
383,535
+14,826
+4% +$589K 0.48% 49
2019
Q1
$14.9M Buy
368,709
+19,645
+6% +$787K 0.48% 50
2018
Q4
$14.5M Sell
349,064
-11,656
-3% -$484K 0.55% 47
2018
Q3
$15.1M Sell
360,720
-21,255
-6% -$818K 0.48% 52
2018
Q2
$13.1M Buy
381,975
+188,256
+97% +$6.43M 0.45% 53
2018
Q1
$6.52M Sell
193,719
-13,654
-7% -$469K 0.25% 73
2017
Q4
$7.13M Sell
207,373
-3,250
-2% -$111K 0.27% 67
2017
Q3
$7.13M Sell
210,623
-3,048
-1% -$98K 0.28% 70
2017
Q2
$6.81M Sell
213,671
-12,346
-5% -$389K 0.26% 74
2017
Q1
$7.34M Sell
226,017
-9,041
-4% -$285K 0.29% 72
2016
Q4
$7.24M Sell
235,058
-11,723
-5% -$358K 0.3% 73
2016
Q3
$7.93M Buy
246,781
+5,227
+2% +$175K 0.33% 64
2016
Q2
$8.07M Sell
241,554
-4,788
-2% -$153K 0.36% 59
2016
Q1
$6.93M Buy
246,342
+181
+0.1% +$5.17K 0.31% 64
2015
Q4
$7.54M Buy
246,161
+7,044
+3% +$222K 0.35% 65
2015
Q3
$7.12M Buy
239,117
+14,843
+7% +$476K 0.34% 68
2015
Q2
$7.13M Sell
224,274
-21,068
-9% -$687K 0.32% 71
2015
Q1
$8.1M Sell
245,342
-1,049
-0.4% -$33.4K 0.37% 68
2014
Q4
$7.27M Sell
246,391
-3,882
-2% -$111K 0.36% 67
2014
Q3
$7.03M Sell
250,273
-6,111
-2% -$172K 0.35% 75
2014
Q2
$7.22M Buy
256,384
+37,480
+17% +$1.07M 0.37% 73
2014
Q1
$6.68M Buy
218,904
+12,434
+6% +$371K 0.37% 72
2013
Q4
$6M Sell
206,470
-28,470
-12% -$829K 0.33% 84
2013
Q3
$6.39M Buy
234,940
+2,242
+1% +$61K 0.37% 82
2013
Q2
$6.18M Buy
+232,698
New +$6.43M 0.35% 79

Other funds holding PFE

Evercore Wealth Management's PFE Position: Q2 2026 in Review

Evercore Wealth Management reduced its Pfizer (PFE) stake by 8.2% in Q2 2026, selling an estimated $217K and leaving 93,409 shares worth $2.25M. The position accounts for 0.03% of the portfolio, ranked #156.

Evercore Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $16M in Q4 2021. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Evercore Wealth Management held 93,409 shares of Pfizer worth $2.25M as of Q2 2026.
  • Evercore Wealth Management sold 8,311 Pfizer shares in Q2 2026, an estimated $217K.
  • Pfizer made up 0.03% of Evercore Wealth Management's portfolio in Q2 2026, its #156 holding.
  • Evercore Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Evercore Wealth Management's Pfizer position peaked at $16M in Q4 2021.
  • 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.